[E-Daily Starin Choi Hee-jae Reporter] The movie "Tazza: The Song of Beelzebub" continues its box office success, ranking second for three consecutive days since its release. Poster for the movie “Tazza: The Song of Beelzebub” (Photo courtesy of CJ ENM) According to the Korean Film Council’s integrated computer network, the movie “Tazza: The Song of Beelzebub” ranked second at the box office on the 25th—its third day in theaters—having drawn a cumulative audience of 448,235. According to distributor CJ ENM, “Tazza: The Song of Beelzebub” is demonstrating the power of word-of-mouth with advance ticket sales and seat occupancy rates that exceed pre-release projections based on advance booking rankings. As of the 26th, the CGV Golden Egg Index stands at 93%, up from the previous day. Even considering that this is the film’s opening week, this figure is higher than the 79% for the previous installment, “Tazza: The Hand of God,” and the 82% for “Tazza: One-Eyed Jack.” Despite its “No Minors Allowed” rating, “Tazza: The Song of Beelzebub” is driving box office success thanks to consistently positive audience reviews. With a high Golden Egg Index and steadily increasing advance ticket sales, all eyes are on whether the film will maintain its box office momentum through word of mouth during the Chuseok holiday. The final installment of the *Tazza* series, *Tazza: The Song of Beelzebub*, is a crime thriller in which Jang Tae-young (Byeon Yo-han)—who thought he had it all thanks to his online casino business—and his best friend of the same name, Park Tae-young (Noh Jae-won), who took everything from him, meet again on the global gambling scene to settle a score. The film stars Byun Yo-han and Noh Jae-won, along with Ayaka Miyoshi, Jo Woo-jin, Yoon Kyung-ho, Tsuyoshi Ihara, Hong Dao, Kim Min-ho, Im Se-mi, and Moon Ji-hoon (Swing).
“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
As the controversy surrounding Baek Jong-won, CEO of The BORN Korea, begins to subside, the company’s net loss for the third quarter of this year has narrowed significantly. The quarterly operating lo…
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…